Daniel Wolff

28PUBLICATIONS
146CO-AUTHORS
Major global burdens of diseaseRadiation therapyPsychology of ageingCardiology (incl. cardiovascular diseases)Gastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 05, 2026
Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic GVHD: results from a multicenter retrospective analysis of a large German-Austrian cohort of the belumosudil MAP.

|Sep 15, 2026
Reduced-dose versus standard-dose total body irradiation before allogeneic haematopoietic stem cell transplantation in adults with acute lymphoblastic leukaemia.

|Aug 10, 2026
Comorbid conditions after allogeneic haematopoietic stem cell transplantation in young adults in Germany-A prospective, multicentre trial.

|Oct 08, 2025
Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantation.

Bernard Ng, Andrew C Harris, Sayeh Abdossamadi

|Oct 01, 2025
Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Ekin Ece Gurer Kluge, Elisabeth Meedt, Julia Feicht

|May 05, 2025
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD.

Katharina M Habenicht, Jana Wanzek, Anna Bootz

Pageof 5

Frequent Collaborators

5 joint publications

Inken Hilgendorf

3 joint publications

Friedrich Stölzel

2 joint publications

Hildegard Greinix

2 joint publications

Matthias Fante